# cn

**Canonical:** https://apis.io/providers/cn/  
**Website:** https://www.ausperbio.com  
**APIs profiled:** 0

cn is the China-region web presence (cn.ausperbio.com) of AusperBio Therapeutics (Hangzhou Ausper Bio / 杭州浩博医药有限公司), a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment toward a functional cure and advancing oligonucleotide therapeutics. AusperBio leverages its proprietary Med-Oligo ASO platform with targeted delivery technologies to apply antisense oligonucleotide (ASO) therapeutics across viral infections, metabolic conditions, genetic disorders, and immune diseases; its lead candidate AHB-137 is an unconjugated ASO advancing through Phase II/III trials for chronic hepatitis B. Surfaced as a portfolio company of Qiming Venture Partners and added to the API Evangelist network as a stub; the company publishes a marketing website but no public developer or API surface.

## Kin Score — 3.3 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 3.3).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Cn Domain Security** — no transport/DNS hardening detected

## Tags

Company, Biotechnology, Pharmaceuticals, Biopharmaceutical, Clinical Stage, Oligonucleotide Therapeutics, Hepatitis B, Drug Development

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/cn/). Scores are computed from the provider's own public artifacts under a published rubric.